Kenneth Kelley

Chief Executive Officer at

IDBiologics, Inc.

66 year

51 connections

Health Technology

Commercial Services

Finance

Profile

Kenneth J. Kelley is a businessperson who founded IntraBiotics Pharmaceuticals, Inc. and Emergent Travel Health, Inc. and who has been at the head of 7 different companies. Presently, he holds the position of Chairman for Seromyx Systems, Inc. and Chairman of Selva Therapeutics, Inc. Mr. Kelley is also on the board of Halozyme Therapeutics, Inc. (former Chairman), Meissa Vaccines, Inc., Actym Therapeutics, Inc. and IDBiologics, Inc. and Managing Director at K2 BioVentures LLC. In his past career Kenneth J. Kelley was Director at Solus Biosystems, Inc., Chairman of Fluxion Biosciences, Inc., General Partner for Latterell Venture Partners, Associate for Institutional Venture Partners, Consultant at McKinsey & Co., Inc., Chairman & Chief Executive Officer for IntraBiotics Pharmaceuticals, Inc., Director at Emergent Travel Health, Inc. and Scientist at Integrated Genetics, Inc. Kenneth J. Kelley received an undergraduate degree from Harvard University and an MBA from Stanford University.

Kenneth Kelley active positions

Companies	Position	Start
K2 BioVentures LLC	Corporate Officer/Principal	07/07/2010
Meissa Vaccines, Inc. Meissa Vaccines, Inc. BiotechnologyHealth Technology Develops vaccines for respiratory syncytial virus and rhinovirus	Director/Board Member	27/03/2019
Actym Therapeutics, Inc. Actym Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immune-oncology therapies	Director/Board Member	-
IDBiologics, Inc. IDBiologics, Inc. BiotechnologyHealth Technology Develops human monoclonal antibodies for the prevention, treatment and cure of infectious diseases	Chief Executive Officer	01/01/2017
Seromyx Systems, Inc. Seromyx Systems, Inc. Pharmaceuticals: MajorHealth Technology Develop immune vaccines, immunotherapies, drugs and diagnostics	Chairman	-
Selva Therapeutics, Inc. Selva Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company dedicated to development of therapeutics for infectious diseases	Chairman	-

All active positions of Kenneth Kelley

Former positions of Kenneth Kelley

Companies	Position	End
HALOZYME THERAPEUTICS, INC.	Chairman	01/01/2015
Latterell Venture Partners Latterell Venture Partners Investment ManagersFinance Latterell Venture Partners invests in companies located in the United States. The firm focuses on biotechnology, research instrument, biomaterial, medical device and diagnostic ventures, pharmaceutical sectors. It provides financing for early stage capital requirements with an investment size of USD 0.05 - 10 million. It makes co-investments and also acts as a lead investor. It takes seat on the board of directors.	Corporate Officer/Principal	01/06/2004
Albert B. Sabin Vaccine Institute, Inc. Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Creates solutions to health threats	Director/Board Member	-
░░░░░░░░ ░░░░░ ░░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-
░░░░░ ░░░░░░░░░░░ ░░░░	░░░░░░░░	░░░░░░░░░░

See the detail of Kenneth Kelley's experience

Training of Kenneth Kelley

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kenneth Kelley's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	19
IntraBiotics Pharmaceuticals, Inc. IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial and antifungal drugs	Health Technology
Halozyme Therapeutics, Inc. Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets	Health Technology
Latterell Venture Partners Latterell Venture Partners Investment ManagersFinance Latterell Venture Partners invests in companies located in the United States. The firm focuses on biotechnology, research instrument, biomaterial, medical device and diagnostic ventures, pharmaceutical sectors. It provides financing for early stage capital requirements with an investment size of USD 0.05 - 10 million. It makes co-investments and also acts as a lead investor. It takes seat on the board of directors.	Finance
Solus Biosystems, Inc. Solus Biosystems, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops tools for measurement of changes in protein conformation	Electronic Technology
Albert B. Sabin Vaccine Institute, Inc. Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Creates solutions to health threats	Commercial Services
Emergent Travel Health, Inc. Emergent Travel Health, Inc. BiotechnologyHealth Technology Provides biotechnical research services	Health Technology
Fluxion Biosciences, Inc. Fluxion Biosciences, Inc. Information Technology ServicesTechnology Services Provides automated patch clamp technology and cell-based assay tools	Technology Services
Institutional Venture Partners Institutional Venture Partners Investment ManagersFinance Institutional Venture Partners invests in companies located in North America and Europe. The firm focuses on a broad range of sectors. It provides financing for growth stage capital requirements with the investment size of USD 15 - 75 millions. It also participates in follow on investments.	Finance
McKinsey & Co., Inc. McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm	Commercial Services
Harvard University Harvard University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Stanford University Stanford University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
MPEX Pharmaceuticals, Inc. MPEX Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops therapies for antibiotic resistance	Commercial Services
Integrated Genetics, Inc. Integrated Genetics, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceuticals preparations	Health Technology
K2 BioVentures LLC
Meissa Vaccines, Inc. Meissa Vaccines, Inc. BiotechnologyHealth Technology Develops vaccines for respiratory syncytial virus and rhinovirus	Health Technology
Actym Therapeutics, Inc. Actym Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immune-oncology therapies	Health Technology
Seromyx Systems, Inc. Seromyx Systems, Inc. Pharmaceuticals: MajorHealth Technology Develop immune vaccines, immunotherapies, drugs and diagnostics	Health Technology
IDBiologics, Inc. IDBiologics, Inc. BiotechnologyHealth Technology Develops human monoclonal antibodies for the prevention, treatment and cure of infectious diseases	Health Technology
Selva Therapeutics, Inc. Selva Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company dedicated to development of therapeutics for infectious diseases	Health Technology